Immunovant's stock fell despite positive batoclimab study results. The company focuses on IMVT-1402 for autoimmune conditions, deferring regulatory decisions.
Immunovant's stock fell despite positive batoclimab study results. The company focuses on IMVT-1402 for autoimmune conditions, deferring regulatory decisions.
Bolloré shares slide following profitability decline in fiscal 2024. Shares dropped by 7.5% amidst significant decreases in adjusted EBITA and slight revenue.
Bolloré shares slide following profitability decline in fiscal 2024. Shares dropped by 7.5% amidst significant decreases in adjusted EBITA and slight revenue.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.
Deutsche Börse's 360T integrates QB's FX algorithms, expanding institutional client options in FX trading. This combines QB's algo expertise into the Spot FX.
The ASX 200 Index rose 0.26% to reach 7,900, driven by positive market sentiment and expectations of the Reserve Bank of Australia (RBA) lowering interest rates in the second half of 2024.